Literature DB >> 23701402

Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer.

Pauline Jardel1, Celine Debiais, Julie Godet, Jacques Irani, Gaelle Fromont.   

Abstract

AIMS: Ductal carcinoma (DC) of the prostate is an entity distinct from the common acinar cancer (AC), both on clinical and morphological aspects. We aimed to analyze the expression of molecules involved in either hormonal signalling or androgen independent pathways, in DC compared to high grade AC. METHODS AND
RESULTS: A tissue microarray was constructed with samples from 24 cases of DC and 27 cases of high grade AC. Immunohistochemistry was performed using antibodies directed against: Ki67; androgen receptor (AR); PSA; 5alpha-reductase 1, 2, 3; oestrogen receptors alpha and beta (ERA and ERB); aromatase; Alpha keto reductase 1C3; Squalene epoxidase (SQLE); BCAR1; Src. Cell proliferation and ERB staining were significantly increased in DC compared to AC. In contrast, the expressions of enzymes SQLE, aromatase, and 5 alpha reductase 2, were higher in AC. Staining for BCAR1 and Src, markers associated with androgen-independent pathways, was increased in DC compared to AC. These differences remained significant after adjusting for pTNM stage.
CONCLUSIONS: These results suggest that the hormone related molecular pathways that drive cancer progression might be different in AC and DC. The decrease in steroid synthesis related enzymes, together with up-regulation of the BCAR1-Src pathway, emphasizes the biological particularities of DC.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23701402     DOI: 10.1111/his.12129

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Immunohistochemical profile of ductal adenocarcinoma of the prostate.

Authors:  Amanda H Seipel; Hemamali Samaratunga; Brett Delahunt; Fredrik Wiklund; Peter Wiklund; Johan Lindberg; Henrik Grönberg; Lars Egevad
Journal:  Virchows Arch       Date:  2014-07-25       Impact factor: 4.064

2.  Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.

Authors:  Aram Kim; Taekmin Kwon; Dalsan You; In Gab Jeong; Heounjeong Go; Yong Mee Cho; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

3.  Squalene Epoxidase Correlates E-Cadherin Expression and Overall Survival in Colorectal Cancer Patients: The Impact on Prognosis and Correlation to Clinicopathologic Features

Authors:  Joo Heon Kim; Chang Nam Kim; Dong Wook Kang
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

4.  Squalene epoxidase expression is associated with breast tumor progression and with a poor prognosis in breast cancer.

Authors:  Nah Ihm Kim; Min Ho Park; Sun-Seog Kweon; Namki Cho; Ji Shin Lee
Journal:  Oncol Lett       Date:  2021-02-04       Impact factor: 2.967

Review 5.  Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy.

Authors:  Yuheng Zou; Hongying Zhang; Feng Bi; Qiulin Tang; Huanji Xu
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

6.  HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker.

Authors:  Cheol Keun Park; Su-Jin Shin; Yoon Ah Cho; Jin Woo Joo; Nam Hoon Cho
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.